Contract W911QY20C0100
Modernatx, Inc. · Department Of Defense · August 11, 2020
Modernatx, Inc. was awarded a federal contract by Department Of Defense (Department Of The Army) on August 11, 2020 for $8.20 billion of work in pharmaceutical preparation manufacturing. Performance is in Cambridge, MA. It was awarded under full and open competition. The contract has been modified 32 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 22, 2023.
Contract details
- PIID
- W911QY20C0100
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Cambridge, MA
- First action
- August 11, 2020
- Latest action
- September 22, 2023
Description
COVID-19 ACTION: DEOBLIGATION MODIFICATION
Modification timeline
-
September 22, 2023Mod P00031$-220.3K
-
June 23, 2023Mod P00030POP EXTENSION$0
-
May 1, 2023Mod P00029DISPOSAL OF EXPIRED MONOVALENT MODERNA DOSES.$508.0K
-
March 3, 2023Mod P00028COVID-19 VACCINE: REMOVING GFP CLAUSE$0
-
October 24, 2022Mod P00027COVID-19 VACCINES- DOSE EXPIRATION INSTRUCTIONS$0
-
October 4, 2022Mod P00026COVID-19 VACCINES: USE OF VACCINE FOR RESEARCH CLAUSE$0
-
September 23, 2022Mod P00025COVID-19 VACCINES: RESCISSION OF HRPAS/DPAS RATING$0
-
August 16, 2022Mod PZ0001COVID-19 VACCINES: DEFINITIZATION OF UNPRICED CHANGE ORDERS ISSUED UNDER MODIFICATIONS P00022 AND P00023 FOR REALIGNMENT OF PRODUCTION TO SUPPLY PEDIATRIC PRIMA$17.48M
-
June 30, 2022Mod P00024COVID-19 VACCINES: EXTENSION AND EXPANSION OF VENDOR MANAGED INVENTORY SOTRAGE$4.85M
-
April 14, 2022Mod P00023COVID-19 VACCINES: AMEND UNPRICED CHANGE ORDER TO REALIGN PRODUCTION FROM ADULT VACCINES TO PEDIATRIC VACCINES$10.50M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $51 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $91 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $32 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $1.1K |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $22 |
| Cardinal Health, Inc. | Department Of Defense | December 31, 2025 | $23 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W911QY20C0100?
Contract W911QY20C0100 is a federal contract awarded to Modernatx, Inc. by Department Of Defense on August 11, 2020 for $8.20 billion of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 32 times since the base award.
Who won contract W911QY20C0100?
Modernatx, Inc. won contract W911QY20C0100 from Department Of Defense.
How much is contract W911QY20C0100 worth?
Contract W911QY20C0100 has obligated $8.20 billion to date.